Barclays
HOOK

Barclays’s HOOKIPA Pharma HOOK Stock Holding History

Barclays’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-275
Closed -$2.02K – 4761
2023
Q1 		$2.02K Hold
275
– – ﹤0.01% 4889
2022
Q4 		$2.23K Sell
275
-577
-68% -$6.25K ﹤0.01% 5077
2022
Q3 		$11K Hold
852
– – ﹤0.01% 4259
2022
Q2 		$14K Sell
852
-312
-27% -$5.17K ﹤0.01% 4518
2022
Q1 		$26K Sell
1,164
-2,018
-63% -$36.2K ﹤0.01% 4352
2021
Q4 		$74K Buy
3,182
+1,545
+94% +$62.1K ﹤0.01% 3787
2021
Q3 		$96K Buy
1,637
+1,394
+574% +$101K ﹤0.01% 3914
2021
Q2 		$22K Sell
243
-1,825
-88% -$243K ﹤0.01% 4462
2021
Q1 		$278K Buy
2,068
+800
+63% +$96.5K ﹤0.01% 3545
2020
Q4 		$141K Sell
1,268
-165
-12% -$17.8K ﹤0.01% 3964
2020
Q3 		$135K Sell
1,433
-105
-7% -$10.7K ﹤0.01% 4073
2020
Q2 		$179K Buy
1,538
+1,207
+365% +$118K ﹤0.01% 4145
2020
Q1 		$28K Sell
331
-666
-67% -$72.9K ﹤0.01% 5520
2019
Q4 		$122K Buy
997
+874
+711% +$74.2K ﹤0.01% 5365
2019
Q3 		$10K Sell
123
-201
-62% -$14.8K ﹤0.01% 6346
2019
Q2 		$22K Buy
+324
New +$34.4K ﹤0.01% 6393

Other funds holding HOOK

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Barclays's HOOK Position: Q2 2023 in Review

Barclays sold out of HOOKIPA Pharma (HOOK) in Q2 2023, closing a stake of 275 shares — an estimated $2.02K sold.

Barclays first reported a position in HOOK in Q2 2019 and held it in 16 quarters. The position peaked at $278K in Q1 2021. 53 funds tracked by Wall St. Rank hold HOOK as of Q2 2023.

  • Barclays reported no remaining HOOKIPA Pharma position as of Q2 2023 after selling out during the quarter.
  • Barclays sold 275 HOOKIPA Pharma shares in Q2 2023, an estimated $2.02K.
  • Barclays first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 16 quarters.
  • Barclays's HOOKIPA Pharma position peaked at $278K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.